1995
DOI: 10.1161/01.cir.92.9.2572
|View full text |Cite
|
Sign up to set email alerts
|

Activation of Blood Coagulation After Cardiac Arrest Is Not Balanced Adequately by Activation of Endogenous Fibrinolysis

Abstract: Our data clearly demonstrate that there is a marked activation of blood coagulation and fibrin formation after prolonged cardiac arrest and CPR in humans that is not balanced adequately by concomitant activation of endogenous fibrinolysis. These changes may contribute to reperfusion disorders, such as the cerebral "no-reflow" phenomenon, by inducing fibrin deposition and formation of microthrombi.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

6
90
0
10

Year Published

2000
2000
2024
2024

Publication Types

Select...
6
4

Relationship

0
10

Authors

Journals

citations
Cited by 238 publications
(109 citation statements)
references
References 25 publications
6
90
0
10
Order By: Relevance
“…However, the lack of amelioration of cerebral hypoperfusion with either osmotic or fibrinolytic therapy was not surprising since the pathophysiology of cerebral no-reflow and delayed hypoperfusion differs fundamentally [41]. The pathophysiology of no-reflow is multifactorial and includes vascular factors like obstruction of the capillary lumen by endothelial flaps [42] or compression by swollen perivascular glial cells [43], blood factors like viscosity changes [44], sludging of erythrocytes [45], the formation of platelet aggregates [46] or an imbalance of blood coagulation [47], and general cardiovascular factors like post-ischaemic hypotension [48]. In contrast, the protracted hypoperfusion after global cerebral ischaemia is a functional disturbance due to an increased vasotonus [41].…”
Section: Discussionmentioning
confidence: 99%
“…However, the lack of amelioration of cerebral hypoperfusion with either osmotic or fibrinolytic therapy was not surprising since the pathophysiology of cerebral no-reflow and delayed hypoperfusion differs fundamentally [41]. The pathophysiology of no-reflow is multifactorial and includes vascular factors like obstruction of the capillary lumen by endothelial flaps [42] or compression by swollen perivascular glial cells [43], blood factors like viscosity changes [44], sludging of erythrocytes [45], the formation of platelet aggregates [46] or an imbalance of blood coagulation [47], and general cardiovascular factors like post-ischaemic hypotension [48]. In contrast, the protracted hypoperfusion after global cerebral ischaemia is a functional disturbance due to an increased vasotonus [41].…”
Section: Discussionmentioning
confidence: 99%
“…[32,33] Therapeutic Hypothermia could be beneficial in this instance since platelets number and function are decreased with temperatures <35°C, and some inhibition of the coagulation cascade develops at temperatures <33°C. [34,35] Vasoconstriction , mediated mainly by thromboxane and endothelin plays a pivotal role in the secondary injury as well.…”
Section: Antithrombotic Rolementioning
confidence: 99%
“…[39][40][41] The coagulation cascade is also activated with ischemia-reperfusion injury leading to intravascular clot formation resulting in microvascular thrombosis in the brain. [42,43] Therapeutic Hypothermia could be beneficial in this instance since platelets number and function are decreased with temperatures <35°C, and some inhibition of the coagulation cascade develops at temperatures <33°C. [44,45] Vasoconstriction, mediated mainly by thromboxane and endothelin plays a pivotal role in the secondary injury as well.…”
Section: Basic Sciencementioning
confidence: 99%